Galderma Laboratories
From Wikipedia, the free encyclopedia
| Galderma | |
 |
|
| Type | Corporation, Joint Partnership |
|---|---|
| Founded | 1981 |
| Headquarters | Sophia Antipolis, France |
| Key people | Humberto Antunes, CEO |
| Industry | Dermatology Pharmaceuticals |
| Products | Cetaphil Clobex Differin Metrogel |
| Website | www.galderma.com |
Galderma Laboratories is a pharmaceutical company dedicated to skin products and dermatology. The corporate headquarters are in Paris, France. Its facilities in the United States include its U.S. headquarters in Fort Worth, Texas and an R&D site in Cranbury, NJ. Other R&D sites include Sophia Antipolis, France and Tokyo, Japan. The company manafactures various prescription topical products to treat acne (Differin), rosacea (MetroGel), and psoriasis (Clobex), and the over-the-counter Cetaphil line of facial and body cleansers and moisturizers. They also have, or are developing, treatments for fungal nail infections, seborrheic dermatitis, non-melanoma skin cancer and photodamage, and hyperpigmentation disorders. Galderma began in 1961 as Owen Laboratories in Fort Worth, and in 1981 joined forces with L'Oréal and Nestlé. The name became Owen-Galderma, and then Galderma.
[edit] External link
- GaldermaUSA (official site)
 |
This French corporation or company article is a stub. You can help Wikipedia by expanding it. |
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
